Navigation Links
Delcath Establishes Queensbury, NY Operations Facility
Date:9/3/2009

NEW YORK, Sept. 3 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH), a Manhattan headquartered medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that it has signed a three-year lease with the option to buy on a 10,000 square foot facility in Queensbury, New York in which it plans to locate manufacturing of its Percutaneous Hepatic Perfusion (PHP(TM)) System. The company anticipates hiring approximately 20 people at this facility by the end of 2009 to establish manufacturing, distribution, research and development capabilities.

"Queensbury is within the fabled upstate-New York region long known as 'Catheter Valley,'" said Eamonn Hobbs, President and CEO of Delcath Systems. "Major medical device companies have located their catheter operations there for decades. As a result, the local labor force is well acquainted with the manufacturing requirements that Delcath will face as it ramps up to full-scale production of the PHP System(TM). And I am personally very excited to be building this business in a region that I know so well."

The Delcath PHP System(TM) is presently being tested in a Phase III study for the regional delivery of melphalan to the liver to treat patients with metastatic cutaneous and ocular melanoma who have unresectable tumors in the liver. The System is designed to deliver significantly higher doses of anti-cancer drugs to a patient's liver while minimizing entry of the drugs into the rest of the patient's circulation. This isolation limits toxicities which result from systemic chemotherapy treatments.

Complete enrollment in the trial is expected by the end of October 2009, with CE Mark approval and a submission to the U.S. Food & Drug Admin
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Delcath Systems to Host Quarterly Update Conference Call
2. Delcath Systems to Host Quarterly Update Conference Call
3. Delcath Systems to Host July 27th Conference Call to Update Investors on Recent Progress
4. Delcath Systems Provides Update on Progress
5. Delcath Systems, Inc. Announces Patient Recruitment Exceeds 90%
6. FDA Grants Delcath Orphan-Drug Designation for Doxorubicin
7. LifeNet Health Establishes The Skin & Wound Allograft Institute
8. Carnegie Mellon Establishes Ray and Stephanie Lane Center for Computational Biology
9. AT&T Establishes New Network Services for Leading Medical Liability Insurer
10. Conference on Elephant Tuberculosis Research Establishes Action Plan at International Symposium on Elephant Conservation
11. Sentry Telecare Establishes Partnering Program to Market Telephone Check-in and Personal Emergency Response Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Diego, Calif. (PRWEB) October 30, 2014 ... longer mutually exclusive concepts in the medical-grade skin ... on the development of uniquely potent topical dermatological ... Health System ( http://www.RefinitySkinScience.com ) with patented COSMEDERM®-7 ... available glycolic acid concentrations (50% and 70%) and ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Radio listeners ... raising questions about the impact of traditional radio commercials ... method most likely to influence a purchasing decision. , ... of 525 consumers conducted by radio marketing company CRN ... categories, isolating the results of respondents who indicated they ...
(Date:10/30/2014)... Toronto, Canada (PRWEB) October 30, 2014 ... the area’s leading provider of non-medical, in-home senior care, ... activity to increased brain health. , The study, performed ... the ages of 60 and 78 over a week-long ... as opposed to daily physical activity. By examining the ...
(Date:10/30/2014)... 2014 USARAD Holdings Inc ... and specialty telemedicine solutions provider, including SecondOpinions.com ... existing teleradiology services at Mission Bend ER, it ... telemedicine services, to the state-of-the-art, 24/7, freestanding ER ... of this innovative partnership, there will be many ...
(Date:10/30/2014)... TX (PRWEB) October 30, 2014 ... released today its 2014 third quarter infection rates ... Texas boasted infection rates of only two percent ... patient satisfaction scores exceeding 98 percent. , “We ... quarter, which included rising satisfaction scores,” said Robert ...
Breaking Medicine News(10 mins):Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 3Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 4Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 3Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 2Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 3Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 2Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 3Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 2Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 3
... 25 OPKO Health, Inc. (Amex: OPK ),today ... C.,Pfenniger, Jr. to its Board of Directors. The company ... Mr. Pfenniger was,appointed to fill the vacancy created by ... created Board position., "The addition of Tom Beier ...
... $154 million, Announces Full Year 2008 Revenue Guidance of $204 ... and Reiterates ... Inc. (Nasdaq:,NUVA), a medical device company focused on developing products ... financial results for the full year ended December,31, 2007 and ...
... HOLLYWOOD, Calif., Jan. 25 IPC The,Hospitalist Company, Inc. ... announced yesterday the initial public offering of 5,200,000,shares of ... of $16.00 per share.,The Company has agreed to sell ... agreed to sell the remaining 1,900,000 shares of,common stock. ...
... Baxa Corporation announces,the launch of a targeted campaign ... delivery of quality therapy to patients, promoting,research and ... patients receiving IV therapy. The new campaign is ... Nurses Day. That day -- January 25, 2008 ...
... many as 30,000 deaths each year, study says , , ... contraceptives greatly reduce their risk of developing ovarian cancer, and ... new study confirms. , The use of oral contraceptives has ... cancer. The authors of the new study say their findings ...
... SAN DIEGO, Jan. 25 Plans put forward ... to healthcare will prove,impractical without more physicians and ... and Nurse Supply: The Missing Piece of the ... Healthcare, the largest,healthcare staffing company in the United ...
Cached Medicine News:Health News:OPKO Health Announces Changes to Board of Directors 2Health News:OPKO Health Announces Changes to Board of Directors 3Health News:NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results 2Health News:NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results 3Health News:IPC The Hospitalist Company, Inc. Prices Initial Public Offering 2Health News:Baxa Corporation Launches Campaign to Recognize IV Nurse Day and Introduce the New PadLock(R) Set Saver 2Health News:Baxa Corporation Launches Campaign to Recognize IV Nurse Day and Introduce the New PadLock(R) Set Saver 3Health News:Oral Contraceptives Cut Ovarian Cancer Risk 2Health News:Oral Contraceptives Cut Ovarian Cancer Risk 3Health News:Report: Too Few Physicians, Nurses to Implement Presidential Candidates' Health Reform Plans 2Health News:Report: Too Few Physicians, Nurses to Implement Presidential Candidates' Health Reform Plans 3
(Date:10/30/2014)... , Oct. 30, 2014  Nektar Therapeutics (Nasdaq: ... the third quarter ended September 30, 2014 on Thursday, ... markets. Howard Robin , president and chief executive ... results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. ... and a live audio-only Webcast of the conference call ...
(Date:10/30/2014)... --  Auxilium Pharmaceuticals , Inc. (NASDAQ: ... today announced financial results for the third quarter ... corporate, commercial, regulatory and clinical development updates from ... pleased with the continued momentum and strong performance ... this quarter, especially the XIAFLEX franchise, which more ...
(Date:10/30/2014)...  TWi Pharmaceuticals, Inc. today announced that it has ... Drug Administration (FDA) on its Abbreviated New Drug Application ... generic equivalent to Eisai Inc.,s Aricept® 23mg.  Aricept® 23mg ... TWi Pharmaceuticals is preparing to launch the product in ... USA , at the earliest time ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 2Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 3Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 4Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 5Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 6Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 7Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 8Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 9Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 10Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 11Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 12Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 13Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 14Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 15Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 16Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 17Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 18Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 19Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 20Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 21Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 22
... EntreMed, Inc. (Nasdaq: ENMD ) announced today that ... with YA Global Master SPV Ltd. ("YA Global"), a fund ... has the option, at its sole discretion, to sell, from ... to YA Global.  Concurrent with the signing of the SEDA, ...
... NEWPORT NEWS, Va., June 28, 2011  Burlington Medical ... new product into its inventory. The Single Swing-Arm Drape ... protects the worker from any scattered beams of radiation ... The black vinyl drape is 39-and-a-half inches wide ...
Cached Medicine Technology:EntreMed Enters into $7.5 Million Equity Facility and Initiates $1.1 Million Drawdown 2EntreMed Enters into $7.5 Million Equity Facility and Initiates $1.1 Million Drawdown 3EntreMed Enters into $7.5 Million Equity Facility and Initiates $1.1 Million Drawdown 4Burlington Medical Supplies Introduces Single Swing-Arm Drape 2
... Ankle Orthosis enables the clinician to ... ankle joint to control muscle imbalance ... a pair of bilateral turnbuckles, controlling ... Simply adjust the turnbuckle to gradually ...
... Protection,Protects the heel while maintaining the ankle ... contact with a soft, cushioning AliPlast™ foam ... and liner cradles the heel in a ... change position freely in bed from side-lying ...
... Pediatric Ankle Cryo/Cuff is specifically designed to ... Using a combination of controlled compression and ... pain. The Pediatric Ankle Cryo/Cuff is ideal ... episodes in hemophilia.,The Pediatric Ankle Cryo/Cuff is ...
SCD Sequential Compression System Intermittent Pneumatic Compression...
Medicine Products: